InvestorsHub Logo
Followers 94
Posts 2734
Boards Moderated 0
Alias Born 09/15/2020

Re: Kgeo post# 637458

Tuesday, 10/03/2023 7:22:34 PM

Tuesday, October 03, 2023 7:22:34 PM

Post# of 688522
No, I really don't think the 45 days matter. We have 2 big catalysts in our future. Despite the importance of other catalysts, like Flaskworks, which I personally think is a HUGE catalyst, Approval and partnership deal are the two that will move the share price the most. I actually think that a partnership agreement will be biggest catalyst. I expect we will get a partnership agreement first of those two. Here are the main reasons:

-BP's access to mainstream media will put us on the map, both in regard to the general medical community, but also to the general investment community.

-MONEY, both to NWBO but also to get basket trials going. The true value is in all the other cancer indications and the news that basket trials will be starting makes the revenue from most solid tumor cancers closer in time

-Validation. Doing a partnership agreement will not only work as a validation for DCVax platform, but also for NWBO.

-Infrastructure in non-gbm cancer indications (likely wouldn't hurt in GBM, even though the consensus seems to think they can handle GBM by themselves)

Good luck to all the longs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News